Search - tctmd.com

Displaying 21 - 40 of 93

Sort: Relevancy | Date

News Conference News EuroPCR 2020

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

Caitlin E. Cox

June 26, 2020

News Daily News

Swedish Data ‘Corroborate’ FFR’s Survival Benefit Seen in RCTs

Caitlin E. Cox

June 03, 2020

News Daily News

FFR for Stable Patients With Intermediate CAD? VA Analysis Stokes Debate

Michael O'Riordan

January 27, 2020

News Daily News

FFR Can Safely Guide PCI Deferral, With Solid Long-term Results: J-CONFIRM

Caitlin E. Cox

January 03, 2020

News Daily News

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Michael O'Riordan

December 05, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

Todd Neale

October 31, 2019

News Opinion Off Script TCT 2019

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

Kwan S. Lee

October 14, 2019

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

News Industry News

Philips launches new IntraSight interventional applications platform to seamlessly integrate intravascular imaging and physiology applications for image-guided procedures

May 20, 2019

News Conference News ACC 2019

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

Michael O'Riordan

March 21, 2019

News Daily News

FFR Values Linked to Quality-of-Life Improvement After PCI in Stable CAD Patients

Todd Neale

September 21, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2018

Caitlin E. Cox

June 01, 2018

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

Caitlin E. Cox

May 22, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

News Conference News EuroPCR 2018

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Michael O'Riordan

May 22, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Daily News

iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI

Todd Neale

November 30, 2017

Advertisement

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

Swedish Data ‘Corroborate’ FFR’s Survival Benefit Seen in RCTs

FFR for Stable Patients With Intermediate CAD? VA Analysis Stokes Debate

FFR Can Safely Guide PCI Deferral, With Solid Long-term Results: J-CONFIRM

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

TCTMD’s Top 10 Most Popular Stories for October 2019

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Philips launches new IntraSight interventional applications platform to seamlessly integrate intravascular imaging and physiology applications for image-guided procedures

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

FFR Values Linked to Quality-of-Life Improvement After PCI in Stable CAD Patients

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

TCTMD’s Top 10 Most Popular Stories for May 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content